NCT02213913 2026-03-11Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell LymphomasUniversity of ChicagoPhase 1/2 Completed55 enrolled 17 charts
NCT02858804 2026-02-11BDH-MCL01Institute of Hematology & Blood Diseases Hospital, ChinaPhase 4 Completed55 enrolled
NCT03710772 2026-02-11Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting51 enrolled
NCT02427620 2025-11-21Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell LymphomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting131 enrolled
NCT00278408 2025-08-26Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's LymphomaUniversität des SaarlandesPhase 3 Completed700 enrolled 21 charts
NCT00878254 2025-07-23Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell LymphomaUniversity of MiamiPhase 2 Completed25 enrolled 14 charts
NCT01184885 2025-05-04A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyThomas Jefferson UniversityPhase EARLY_PHASE1 Completed7 enrolled 8 charts